Ildong Holdings Co., Ltd. (KRX:000230)
6,920.00
+60.00 (0.87%)
At close: Jun 5, 2025, 3:30 PM KST
Ildong Holdings Revenue
Ildong Holdings had revenue of 149.76B KRW in the quarter ending March 31, 2025, a decrease of -7.47%. This brings the company's revenue in the last twelve months to 645.47B, down -0.12% year-over-year. In the year 2024, Ildong Holdings had annual revenue of 657.57B with 2.99% growth.
Revenue (ttm)
645.47B
Revenue Growth
-0.12%
P/S Ratio
0.12
Revenue / Employee
8.96B
Employees
72
Market Cap
78.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 657.57B | 19.12B | 2.99% |
Dec 31, 2023 | 638.45B | -37.09B | -5.49% |
Dec 31, 2022 | 675.54B | 83.17B | 14.04% |
Dec 31, 2021 | 592.37B | -4.09B | -0.69% |
Dec 31, 2020 | 596.47B | 304.25B | 104.12% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |